TABLE 3.
18F-FDG Uptake in Case of Malignant Transformation of Endometriosis
| Reference | No. Patients (Patient-Based 18F-FDG PET/CT Positivity Rate) | Location of Malignant Transformation of Endometriosis | SUVmax in Case of Malignant Transformation of Endometriosis Median or Mean (Range) |
|---|---|---|---|
| Kusunoki et al18 | 11 (5/11) | Ovary | 8.4 (2–18) |
| Li et al19 | 1 (1/1) | Rectosigmoid | 15.7 |
| Yoshida et al31 | 1 (1/1) | Groin, right pelvic lymph nodes | NA |
| Wang et al32 | 1 (1/1) PET/MRI, delay between 18F-FDG administration and acquisition of images not provided |
Abdominal wall and lymph nodes | 9.61 and 4.25 |